1) Ramnath N, Dilling TJ, Harris LJ,el al. Treatment of stage HI non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5 Suppl): e314S-e340S.
2) Albain KS, Swann RS, Rusch VWt et al. Radiotherapy plus chemotherapy with or without surgical resection for stage HI non-small-cell lung cancer: a phase Iff randomised controlled trial. Lancet, 2009; 374 (9687): 379-386.
3) 渡辺 俊一. 根治を目指す手術戦略.日外会誌.2015; 116: 324-328.
4) Watanabe S, Asamura H, Miyaoka E, et al. Results of T4 surgical cases in the Japanese Lung Cancer Registry Study: should mediastinal fat tissue invasion really be included in the T4 category? J Thorac Oncol. 2013; 8:759-765.
5) Kimitoh H, Kato H, Tsuboi M, et al. Phase Π trial of preoperative chemoradiotherapy fbUowed by surgical resection in patients with superior sulcus non-small-cell lung cancers* report of Japan Clinical Oncology Group trial 9806. 2008; 26· 644-649.
6) Rusch VW; Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas- long term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Oncol. 2007; 25: 313-318.
7) Kawaguchi K, 'Yokoi K, Niwa H, et al. A prospective, multi-institutional phase II study of induction chemoradiotherapy followed by surgery in patients with non-small cell lung cancer involving the chest wall (CJLSG0801). Lung Cancer. 2017;104: 79-84.